A
Acumen Pharmaceuticals (ABOS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acumen Pharmaceuticals (ABOS)
Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.
- USD1.02
- USD1.02
- USD0.98
- USD3.92
- -7.50%
- --
- 129.71k
- 215.20k
- 65M
- 0.86
- -72.50%
Stock News
4 hours ago
Stock-market bulls face inflation test this week, but trade talks may set the tone
MarketWatch
7 hours ago
Adtalem Global Education: A Picks-And-Shovels Play On The U.S. Healthcare Labor Crisis
SeekingAlpha
8 hours ago
The Real Brokerage Inc. 2025 Q1 - Results - Earnings Call Presentation
SeekingAlpha
8 hours ago
Invesco Rising Dividends Fund Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
